162 related articles for article (PubMed ID: 32397195)
41. Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways.
Liu J; Li Q; Liu Z; Lin L; Zhang X; Cao M; Jiang J
Oncol Rep; 2016 Jun; 35(6):3363-70. PubMed ID: 27004568
[TBL] [Abstract][Full Text] [Related]
42. Cytotoxicity of the beta-carboline alkaloids harmine and harmaline in human cell assays in vitro.
Jiménez J; Riverón-Negrete L; Abdullaev F; Espinosa-Aguirre J; Rodríguez-Arnaiz R
Exp Toxicol Pathol; 2008 Aug; 60(4-5):381-9. PubMed ID: 18430551
[TBL] [Abstract][Full Text] [Related]
43. MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.
Moore C; Parrish JK; Jedlicka P
PLoS One; 2017; 12(5):e0178028. PubMed ID: 28542597
[TBL] [Abstract][Full Text] [Related]
44. EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells.
Hu HM; Zielinska-Kwiatkowska A; Munro K; Wilcox J; Wu DY; Yang L; Chansky HA
J Orthop Res; 2008 Jun; 26(6):886-93. PubMed ID: 18271016
[TBL] [Abstract][Full Text] [Related]
45. PLEKHG3 enhances polarized cell migration by activating actin filaments at the cell front.
Nguyen TT; Park WS; Park BO; Kim CY; Oh Y; Kim JM; Choi H; Kyung T; Kim CH; Lee G; Hahn KM; Meyer T; Heo WD
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10091-6. PubMed ID: 27555588
[TBL] [Abstract][Full Text] [Related]
46. Actin cytoskeleton regulates functional anchorage-migration switch during T-cadherin-induced phenotype modulation of vascular smooth muscle cells.
Frismantiene A; Kyriakakis E; Dasen B; Erne P; Resink TJ; Philippova M
Cell Adh Migr; 2018 Jan; 12(1):69-85. PubMed ID: 28524745
[TBL] [Abstract][Full Text] [Related]
47. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
48. EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma.
He S; Huang Q; Hu J; Li L; Xiao Y; Yu H; Han Z; Wang T; Zhou W; Wei H; Xiao J
Br J Cancer; 2019 Nov; 121(11):922-933. PubMed ID: 31649319
[TBL] [Abstract][Full Text] [Related]
49. MIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamics.
Kpetemey M; Chaudhary P; Van Treuren T; Vishwanatha JK
Oncotarget; 2016 Aug; 7(34):54913-54924. PubMed ID: 27462783
[TBL] [Abstract][Full Text] [Related]
50. Detection of EWS/FLI-1 fusion in non-Ewing soft tissue tumors.
Trancău IO; Huică R; Surcel M; Munteanu A; Ursaciuc C
J Med Life; 2015; 8(1):85-9. PubMed ID: 25914746
[TBL] [Abstract][Full Text] [Related]
51. [Comparative research of normal and transformed fibroblast spreading. The role of microfilament polymerization and actin-myosin contractility].
Shutova MS; Aleksandrova AIu
Tsitologiia; 2010; 52(1):41-51. PubMed ID: 20302016
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma.
Tosso PN; Kong Y; Scher L; Cummins R; Schneider J; Rahim S; Holman KT; Toretsky J; Wang K; Üren A; Brown ML
J Med Chem; 2014 Dec; 57(24):10290-303. PubMed ID: 25432018
[TBL] [Abstract][Full Text] [Related]
53. The role of Rho GTPases in the regulation of the rearrangement of actin cytoskeleton and cell movement.
Begum R; Nur-E-Kamal MS; Zaman MA
Exp Mol Med; 2004 Aug; 36(4):358-66. PubMed ID: 15365255
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton.
Song Y; Maul RS; Gerbin CS; Chang DD
Mol Biol Cell; 2002 Apr; 13(4):1408-16. PubMed ID: 11950948
[TBL] [Abstract][Full Text] [Related]
55. SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
Tang SW; Bilke S; Cao L; Murai J; Sousa FG; Yamade M; Rajapakse V; Varma S; Helman LJ; Khan J; Meltzer PS; Pommier Y
Clin Cancer Res; 2015 Sep; 21(18):4184-93. PubMed ID: 25779942
[TBL] [Abstract][Full Text] [Related]
56. Harmine suppresses bladder tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Hai-Rong C; Xiang H; Xiao-Rong Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910851
[TBL] [Abstract][Full Text] [Related]
57. IQGAPs as Key Regulators of Actin-cytoskeleton Dynamics.
Watanabe T; Wang S; Kaibuchi K
Cell Struct Funct; 2015; 40(2):69-77. PubMed ID: 26051604
[TBL] [Abstract][Full Text] [Related]
58. RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1.
Erkizan HV; Schneider JA; Sajwan K; Graham GT; Griffin B; Chasovskikh S; Youbi SE; Kallarakal A; Chruszcz M; Padmanabhan R; Casey JL; Üren A; Toretsky JA
Nucleic Acids Res; 2015 Jan; 43(2):1069-80. PubMed ID: 25564528
[TBL] [Abstract][Full Text] [Related]
59. Cytotoxicity of alkaloids isolated from Peganum harmala seeds.
Lamchouri F; Zemzami M; Jossang A; Abdellatif A; Israili ZH; Lyoussi B
Pak J Pharm Sci; 2013 Jul; 26(4):699-706. PubMed ID: 23811445
[TBL] [Abstract][Full Text] [Related]
60. Synthetic polyamines promote rapid lamellipodial growth by regulating actin dynamics.
Nedeva I; Koripelly G; Caballero D; Chièze L; Guichard B; Romain B; Pencreach E; Lehn JM; Carlier MF; Riveline D
Nat Commun; 2013; 4():2165. PubMed ID: 23893126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
